Genomics, Epigenetics, and Hearing Loss in Neurofibromatosis Type 2-Reference-Cited by-同舟云学术

Genomics, Epigenetics, and Hearing Loss in Neurofibromatosis Type 2

Published:2020-03-05 Issue:5 Volume:41 Page:e529-e537
ISSN:1531-7129
Container-title:Otology & Neurotology
language:en
Short-container-title:

Author:

Dinh Christine T.,Nisenbaum Eric,Chyou Darius,Misztal Carly,Yan Denise,Mittal Rahul,Young Juan,Tekin Mustafa,Telischi Fred,Fernandez-Valle Cristina,Liu Xue-Zhong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Clinical Neurology,Sensory Systems,Otorhinolaryngology

Reference86 articles.

1. Neurofibromatosis 2;Evans;GeneReviews((R)),1993

2. Genetic severity score predicts clinical phenotype in NF2;Halliday;J Med Genet,2017

3. Hearing restoration in neurofibromatosis Type II patients;Lee;Yonsei Med J,2016

4. A clinical study of type 2 neurofibromatosis;Evans;Quart J Med,1992

5. Neurofibromatosis 2 (NF2): Clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity;Parry;Am J Med Genet,1994

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions;Oncology and Therapy;2024-05-17

2. LINE-1 global DNA methylation, iron homeostasis genes, sex and age in sudden sensorineural hearing loss (SSNHL);Human Genomics;2023-12-14

3. Updates on Tumor Biology in Vestibular Schwannoma;Otolaryngologic Clinics of North America;2023-06

4. Diagnostic and Therapeutic Strategy for Vagal Schwannoma: Case Series and Literature Review;Medicina;2023-05-24

5. The genetic landscape and possible therapeutics of neurofibromatosis type 2;Cancer Cell International;2023-05-23